In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Women who deliver their first baby with a cesarean section face an increased risk of adverse reproductive outcomes in subsequent pregnancies, according to…
NEW YORK (Reuters Health) – In patients with chronic coronary artery disease, prasugrel overcomes high on-clopidogrel platelet reactivity more effectively than doubling the dose of clopidogrel, results of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Thoracoscopic unilateral extended thymectomy (TUET) is “the best treatment option” for patients undergoing surgery for nonthymomatous myasthenia gravis, clinicians from Romania conclude in…
NEW YORK (Reuters Health) – Hospitalized nonsurgical patients (medical patients and those with acute stroke) should receive pharmacologic venous thromboembolism (VTE) prophylaxis, unless the risk for bleeding outweighs…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – After organ transplantation, the overall risk of any new malignancy doubles, according to a new report from the U.S. National Cancer Institute. The…
NEW YORK (Reuters Health) – All women found to have vulvar intraepithelial neoplasia (VIN) require some form of treatment and follow-up surveillance, according to recommendations from The American…
NEW YORK (Reuters Health) – The institution of lipid-lowering therapy has significantly reduced mortality in patients with homozygous familial hypercholesterolemia (FH), researchers from South Africa report in the…
NEW YORK (Reuters Health) – For women with advanced breast cancer, capecitabine provides similar overall survival with less toxicity compared with classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line…
